Agenzia Italiana del Farmaco
Monitoring of oral antivirals for COVID-19: second report published - Monitoring of oral antivirals for COVID-19: second report published
Monitoring of oral antivirals for COVID-19: second report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of oral antivirals currently available for treating COVID-19. The monitoring was carried out through the AIFA registry, which was developed in implementation of the Decree of the Ministry of Health 29 November 2021 and published in the Official Gazette no. 295 of 13 December 2021.
Published on: 28 January 2022